NCT04428021View on ClinicalTrials.gov

Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 15, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

October 31, 2021

Conditions
COVID-19
Interventions
DRUG

Standard Therapy Protocol (STP)

Standard Therapy Protocol according to the best evidence treatment recommended by the Regional Health System emergency committee

OTHER

STP + Standard Plasma (SP)

Transfusion of three Standard Plasma Units (SP) on day 1,3,5 in addition to STP

OTHER

STP + COVID-19 Convalescent Plasma (CP)

Transfusion of three SARS-Cov-2 neutralizing antibodies positive Plasma Units (CP) on day 1,3,5 in addition to STP

Trial Locations (1)

10126

AO Città della salute e della scienza di Torino, Torino

All Listed Sponsors
lead

A.O.U. Città della Salute e della Scienza

OTHER

NCT04428021 - Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure | Biotech Hunter | Biotech Hunter